Anacor Pharmaceuticals to Present at Upcoming Investor Conferences - EON: Enhanced Online News (press release)

Anacor Pharmaceuticals to Present at Upcoming Investor Conferences EON: Enhanced Online News (press release) Anacor is also developing AN2718 as a topical agent product candidate for the treatment of onychomycosis and skin fungal infections and AN2898 as a topical anti-inflammatory product candidate for the treatment of disease of the skin and atopic dermatitis. and more » Link To Article